| Literature DB >> 34589128 |
Berhanu Adugna1, Bekele Sharew2, Mohabaw Jemal3.
Abstract
BACKGROUND: Bacterial urinary tract infection is among the most common community and hospital-acquired infections. Therefore, to know the status of the community and hospital-acquired urinary tract infection, antimicrobial susceptibility patterns, and associated factors among urinary tract infection profiles are essential to physicians and health workers to implement appropriate intervention.Entities:
Year: 2021 PMID: 34589128 PMCID: PMC8476241 DOI: 10.1155/2021/5553356
Source DB: PubMed Journal: Int J Microbiol
Sociodemographic characteristics of the study participant among the community and hospital-acquired UTI at Dessie Referral Hospital.
| Characteristics ( | Negative, | Positive, | Total, | |
|---|---|---|---|---|
| Sex | Male | 122 (86.5) | 19 (13.5) | 141 (33.4) |
| Female | 200 (76.7) | 81 (23.3) | 281 (66.6) | |
|
| ||||
| Age | 0–14 | 55 (83.3) | 11 (16.6) | 66 (15.6) |
| 15–29 | 77 (70) | 33 (30) | 110 (26) | |
| 30–44 | 96 (84.2) | 18 (15.7) | 114 (27) | |
| 45–59 | 60 (83.3) | 12 (16.7) | 72 (17) | |
| >60 | 34 (56.6) | 26 (43.3) | 60 (14.2) | |
|
| ||||
| Education | Illiterate | 89 (71.7) | 35 (28.2) | 124 (29.4) |
| Read and write only | 106 (77.4) | 31 (22.6) | 137 (32.4) | |
| Up to grades 8 complete | 86 (81) | 20 (19) | 106 (25) | |
| Up to grade 12 complete | 17 (70) | 7 (29) | 24 (5.6) | |
| University/college and above | 24 (77.4) | 7 (22.6) | 31 (7.3) | |
|
| ||||
| Residence | Urban | 185 (77.7) | 53 (22.3) | 238 (56.4) |
| Rural | 137 (72.8) | 51 (27.2) | 188 (43.6) | |
|
| ||||
| Monthly income | Lower (<500 EBR) | 150 (70) | 64 (30) | 214 (50.7) |
| Medium (5001–1000) | 106 (83.4) | 21 (16.6) | 127 (30) | |
| Higher (>1001 EBE) | 66 (81) | 15 (8.5) | 81 (19.3) | |
|
| ||||
| Pregnancy status ( | Yes | 10 (50) | 10 (50) | 20 (10) |
| No | 136 (78.8) | 43 (21.2) | 179 (90) | |
|
| ||||
| Diabetics (CDs) | Yes | 29 (40.2) | 43 (59.7) | 72 (17) |
| No | 293 (83.7) | 57 (16.3) | 350 (83) | |
|
| ||||
| History of urinary tract obstruction | Yes | 17 (42.5) | 23 (57.5) | 40 (9.5) |
| No | 305 (80.9) | 77 (19.1) | 382 (90.5) | |
|
| ||||
| Previous exposure to antibiotics | Yes | 90 (58.4) | 64 (41.5) | 154 (36.4) |
| No | 232 (86.5) | 36 (13.4) | 268 (63.6) | |
|
| ||||
| Recurrence urinary tract infection | Yes | 107 (64) | 60 (36) | 167 (40) |
| No | 215 (89.1) | 40 (10.9) | 255 (60) | |
|
| ||||
| History of renal calculi | Yes | 38 (77.5) | 11 (22.4) | 49 (11.6) |
| No | 303 (81.4) | 70 (18.6) | 373 (88.4) | |
|
| ||||
| Contraceptive method ( | Yes | 16 (84.2) | 3 (15.8) | 19 (7.5) |
| No | 178 (78.3) | 56 (21.7) | 234 (92.5) | |
|
| ||||
| Waiting time in hospital ( | 48–72 hours | 45 (80.4) | 11 (19.6) | 56 (34.3) |
| >72 hours | 68 (63.6) | 39 (36.4) | 107 (65.7) | |
|
| ||||
| History of catheterization ( | Yes | 21 (41.2) | 30 (58.8) | 51 (31.2) |
| No | 92 (82.1) | 20 (17.9) | 112 (68.8) | |
|
| ||||
| Duration of catheterization ( | <One week | 8 (53.3) | 7 (46.7) | 15 (28.3) |
| >One week | 13 (34.2) | 25 (65.8) | 38 (71.7) | |
Distribution of culture among community versus hospital-acquired UTI groups of patients at Dessie Referral Hospital, Dessie.
| UTI types | Urine cultured | Cultured positive cases | Percentage |
|
|
|---|---|---|---|---|---|
| CAUTI | 259 | 50 | 19.3 | 6.537 | 0.011 |
| HAUTI | 163 | 50 | 30.7 | ||
| Total | 422 | 100 | 23.7 |
Note: by chi-squire, X2 = 6.537, df = 1, P=0.011; HAUTI: hospital-acquired UTI; CAUTI: community-acquired UTI.
Figure 1Bacterial growth results in the culture media from a total urine sample processed at Dessie Referral Hospital, Dessie.
Distribution of bacterial isolated among CAUTI and HAUTI at Dessie Referral Hospital Dessie.
| Isolated organism | Type of UTI | ||||
|---|---|---|---|---|---|
| CAUTI ( | HAUTI ( | Total | |||
| Male | Female | Male | Female | ||
|
| 5 (19.2) | 21 (80.8) | 4 (22.2) | 14 ( (77.8) | 44 (42.72) |
|
| 3 (25) | 9 (75) | 3 (23) | 10 (77) | 25 ( (24.27) |
| CONS | 1 (12.5) | 7 (87.5) | 1 (16.7) | 5 (83.3) | 14 (13.6) |
| 1 (50) | 1 (50) | 1 (20) | 4 (80) | 7 (6.78) | |
| 0 (0) | 1 (100) | 0 (0) | 3 (100) | 4 (3.88) | |
| 0 (0) | 1 (100) | 0 (0) | 2 (100) | 3 (2.91) | |
| 0 (0) | 0 (0) | 0 (0) | 3 (100) | 3 (2.91) | |
| 0 (0) | 0 (0) | 0 (0) | 2 (100) | 2 (1.94) | |
| 0 (0) | 0 (0) | 0 (0) | 1 (100) | 1 (0.99) | |
| Total | 10 (20) | 40 (80) | 9 (17) | 44 ( (83) | 103 (100) |
Note: CONs = coagulase-negative Staphylococcus, HAUTI = hospital-acquired UTI, CAUTI = community-acquired UTI.
Figure 2Distribution of isolates varies in the duration of catheterization at Dessie Referral Hospital.
Bivariate and multivariate analyses of risk factors associated with community and hospital-acquired UTI among Dessie Referral Hospital.
| Variable | Hospital-acquired | Community-acquired | ||||||
|---|---|---|---|---|---|---|---|---|
| Corollary (95% CI) | AOR (95%CI) | Corollary (95% CI) | AOR (95%CI) | |||||
|
| ||||||||
| Male | 1 | 1 | ||||||
| Female | 3.01 (1.336–6.803) | 0.008 | 8.93 (1.79–44.5) | 0.008 | 2.3 (1.10–4.94) | 0.026 | 0.4 (0.072–2.06) | 0.266 |
|
| ||||||||
|
| ||||||||
| 0–14 | 0.17 (0.05–0.581) | 0.005 | 0.33 (0.045–2.5) | 0.280 | 0.85 (0.21–3.3) | 0.811 | ||
| 15–29 | 0.17 (0.063–0.463) | ≤0.001 | 0.13 (0.02–0.79) | 0.027 | 2.8 (0.86–9.13) | 0.085 | 3 (0.476–19.24) | 0.240 |
| 30–44 | 0.06 (0.018–0.218) | ≤0.001 | 0.06 (0.06–0.6) | 0.008 | 1.3 (0.37–4.25) | 0.707 | ||
| 45–59 | 0.27 (0.094–0.791) | 0.017 | 0.26 (0.04–1.85) | 0.180 | 0.4 (0.081–1.9) | 0.247 | ||
| >60 | 1 | 1 | ||||||
|
| ||||||||
|
| ||||||||
| Illiterate | 1.29 (0.291–5.766) | 0.733 | 1.5 (0.44–4.82) | 0.553 | ||||
| Read and write only | 1.23 (0.287–5.233) | 0.784 | 0.644 (0.18–2.3) | 0.499 | ||||
| 1–8 grade complete | 0.60 (0.129–2.794) | 0.515 | 0.92 (0.26–3.26) | 0.893 | ||||
| Up to grade 12 complete | 1.17 (0.133–10.22) | 0.889 | 1.63 (0.3657.36) | 0.521 | ||||
| University/college | 1 | 1 | ||||||
|
| ||||||||
|
| ||||||||
| Urban | 1 | 1 | ||||||
| Rural | 1.71 (0.874–3.374) | 0.117 | 2.93 (0.969–8.88) | 0.057 | 1.26 (0.86–2.33) | 0.459 | ||
|
| ||||||||
|
| ||||||||
| Lower (<500EBR) | 1.47 (0.584–3.719) | 0.412 | 1.484 (0.65–3.4) | 0.353 | ||||
| Medium (5001–1000EBR) | 0.61 (0.203–1.821) | 0.374 | 1.1 (0.449–2.75) | 0.820 | ||||
| Higher (>1001EBE) | 1 | 1 | ||||||
|
| ||||||||
|
| ||||||||
| Yes | 2.39 (0.54–10.612) | 0.252 | 3.72 (1.1–12.53) | 0.034 | 3.340 (0.78–14.10) | 0.102 | ||
| No | 1 | 1 | ||||||
|
| ||||||||
|
| ||||||||
| Yes | 9.02 (4.130–19.71) | ≤0.001 | 6.70 (1.994–22.53) | 0.002 | 5.243 (2.3–11.9) | ≤0.001 | 1.751 (0.47–6.49) | 0.402 |
| No | 1 | 1 | ||||||
|
| ||||||||
|
| ||||||||
| Yes | 6.10 (2.082–13.85) | ≤0.001 | 2.69 (0.712–10.18) | 0.144 | 1.650 (.312–8.8) | 0.553 | ||
| No | 1 | 1 | ||||||
|
| ||||||||
|
| ||||||||
| Yes | 4.13 (2.028–8.420) | ≤0.001 | 5.69 (1.84–17.59) | 0.003 | 5.8 (2.944–11.5) | ≤0.001 | 4.427 (1.21–16.15) | 0.024 |
| No | 1 | 1 | ||||||
|
| ||||||||
|
| ||||||||
| Yes | 4.65 (2.229–9.701) | ≤0.001 | 1.62 (0.499–5.23) | 0.423 | 3.4 (1.75–6.604) | ≤0.001 | 1.023 (0.31–3.36) | 0.970 |
| No | 1 | 1 | ||||||
|
| ||||||||
|
| ||||||||
| Yes | 6.17 (1.154–32.96) | 0.033 | 9.47 (0.58–153.3) | 0.114 | 1.65 (0.61–0.23) | 0.331 | ||
| No | 1 | 1 | ||||||
|
| ||||||||
|
| ||||||||
| Yes | 0.000 (0.000---) | 0.999 | 0.9 (0.24–3.402) | 0.880 | ||||
| No | 1 | 1 | ||||||
|
| ||||||||
|
| ||||||||
| 48–72 hours | 1 | |||||||
| >72 hours | 2.35 (1.089–5.056) | 0.029 | 2.35 (0.77–7.18) | |||||
|
| ||||||||
|
| ||||||||
| Yes | 6.92 (3.284–14.57) | ≤0.001 | 3.9 (1.323–11.5) | |||||
| No | 1 | |||||||
|
| ||||||||
|
| ||||||||
| <One week | 1 | |||||||
| >One week | 2.20 (0.652–7.413) | 0.204 | ||||||
Note. COR: crude odd ratio; AOR: adjusted odd ratio; CI: confidence interval; EBR: Ethiopian birr; 1: reference.
Antimicrobial susceptibility pattern of hospital-acquired urinary tract infection at Dessie Referral Hospital, Dessie.
| Isolates ( | Antimicrobial agent, | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gram-positive | CIP | TE | F | SXT | CN |
| AMP | VA | ||||
| | S | 9 (69.2) | 2 (15.4) | 9 (60.2) | 5 (38.5) | 10 (77) | 4 (33.3) | ND | ND | |||
| I | 0 (0) | 2 (15.4) | 0 (0) | 0 (0) | 1 (7.7) | 1 (8.3) | ||||||
| R | 4 (30.8) | 9 (69.2) | 4 (30.8) | 8 (61.5) | 2 (15.4) | 7 (58.3) | ||||||
|
| ||||||||||||
| | S | 3 (50) | 1 (16.7) | 4 (66.7) | 1 (16.7) | 4 (66.7) | 1 (16.7) | ND | ND | |||
| I | 1 (16.7) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||||||
| R | 2 (33.3) | 5 (83.3) | 2 (33.3) | 5 (83.3) | 2 (23.3) | 5 (83.3) | ||||||
|
| ||||||||||||
| | S | 1 (50) | 0 (0) | 2 (100) | ND | ND | 1 (50) | 1 (50) | 2 (100) | |||
| I | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||||||
| R | 1 (50) | 2 (100) | 0 (0) | 1 (50) | 1 (50) | 0 (0) | ||||||
|
| ||||||||||||
| Gram-negative | CIP | T | F | SXT | CN | AMP | MEM | CRO | NA | AMC | CAZ | |
| | S | 12 (66.7) | 5 (29) | 16 (88.9) | 8 (44.4) | 12 (66.7) | 1 (5.6) | 18 (100) | 15 (83.3) | 15 (83.3) | 5 (27.8) | 12 (66.7) |
| I | 0 (0) | 2 (11) | 1 (5.6) | 0 (0) | 1 (5.6) | 2 (11.1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| R | 6 (33.3) | 11 (61) | 1 (5.6) | 10 (55.6) | 5 (27.7) | 15 (83.3) | 0 (0) | 3 (16.7) | 3 (16.7) | 13 (72.2) | 6 (33.3) | |
|
| ||||||||||||
| | S | 3 (100) | 0 (0) | 3 (100) | 0 (0) | 1 (33.3) | 0 (0) | 3 (100) | 2 (66.7) | 3 (100) | 1 (33.3) | 2 (66.7) |
| I | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| R | 0 (0) | 3 (100) | 0 (0) | 3 (100) | 2 (66.7) | 3 (100) | 0 (0) | 1 (33.3) | 0 (0) | 2 (66.7) | 1 (33.3) | |
|
| ||||||||||||
| | S | 3 (60) | 0 (0) | 5 (100) | 2 (40) | 3 (60) | 0 (0) | 5 (100) | 2 (40) | 4 (80) | 0 (0) | 4 (80) |
| I | 1 (20) | 1 (20) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (20) | 1 (20) | 0 (0) | |
| R | 1 (20) | 4 (80) | 0 (0) | 3 (60) | 2 (30) | 5 (100) | 0 (0) | 3 (60) | 0 (0) | 4 (80) | 1 (20) | |
|
| ||||||||||||
| | S | 1 (50) | 0 (0) | 2 (100) | 0 (0) | 1 (50) | 0 (0) | 2 (100) | 0 (0) | 1 (50) | 0 (0) | 1 (50) |
| I | 1 (50) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 0 (0) | |
| R | 0 (0) | 2 (100) | 0 (0) | 2 (100) | 0 (0) | 2 (100) | 0 (0) | 2 (100) | 0 (0) | 2 (100) | 1 (50) | |
|
| ||||||||||||
| | S | 0 (0) | ND | ND | ND | 2 (66.7) | ND | 3 (100) | ND | ND | ND | ND |
| I | 1 (33.3) | 0 (0) | 0 (0) | |||||||||
| R | 2 (66.7) | 1 (33.3) | 0 (0) | |||||||||
|
| ||||||||||||
| | S | 1 (100) | 0 (0) | ND | 0 (0) | 0 (0) | ND | 1 (100) | ND | ND | ND | ND |
| I | 0 (0) | 1 (100) | 0 (0) | 1 (100) | 0 (0) | |||||||
| R | 0 (0) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | |||||||
|
| ||||||||||||
| Total | S | 33 (37.4) | 8 (16) | 41 (83.6) | 15 (33) | 33 (64.7) | 7 (15) | 33 (97) | 21 (70) | 23 (82) | 6 (21) | 19 (68) |
| I | 5 (9.4) | 6 (4) | 1 (2) | 0 (0) | 4 (7.8) | 3 (6) | 0 (0) | 0 (0) | 2 (7) | 1 (4) | 0 (0) | |
| R | 15 (28) | 36 (80) | 7 (14.4) | 32 (67) | 14 (27.4) | 38 (79) | 1 (3) | 9 (30) | 3 (11) | 21 (75) | 9 (32) | |
Note: AMP, ampicillin; CIP, ciprofloxacin; CRO, ceftriaxone; AMC, amoxicillin-clavulanate; CN, gentamicin; F, nitrofurantoin; SXT, cotrimoxazole; NA, nalidixic acid; CAZ, ceftazidime; MEM, meropenem; VA, vancomycin; TE, tetracycline; ND, not done.
Antimicrobial susceptibility pattern of community-acquired urinary tract infection at Dessie Referral Hospital, Dessie.
| Isolates( | Antimicrobial agent, | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gram-positive | CIP | TE | F | SXT | CN |
| AMP | VA | ||||
| | S | 8 (66.7) | 1 (8.3) | 12 (100) | 5 (41.7) | 9 (75) | 7 (58.3) | ND | ND | |||
| I | 0 (0) | 3 (25) | 0 (0) | 1 (8.3) | 0 (0) | 1 (8.3) | ||||||
| R | 4 (33.3) | 8 (66.7) | 0 (0) | 6 (8.3) | 3 (25) | 4 (33.3) | ||||||
|
| ||||||||||||
| | S | 6 (75) | 3 (37.5) | 7 (87) | 5 (62.5) | 7 (87.5) | 5 (62.5) | ND | ND | |||
| I | 1 (12.5) | 1 (12.5) | 1 (12.5) | 0 (0) | 0 (0) | 0 (0) | ||||||
| R | 1 (12) | 4 (50) | 0 (0) | 3 (37.5) | 1 (12.5) | 3 (37.5) | ||||||
|
| ||||||||||||
| | S | 1 (100) | 0 (0) | 1 (100) | ND | ND | 0 (0) | 0 (0) | 0 (0) | |||
| I | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | ||||||
| R | 0 (0) | 1 (100) | 0 (0) | 1 (100) | 1 (100) | 0 (0) | ||||||
|
| ||||||||||||
| Gram-negative | CIP | T | F | SXT | CN | AMP | MEM | CRO | NA | AMC | CAZ | |
| | S | 24 (92.3) | 9 (34.5) | 25 (96.2) | 12 (46.2) | 21 (80.8) | 5 (19.2) | 26 (100) | 21 (80.8) | 18 (69.2) | 11 (42.3) | 22 (84.6) |
| I | 1 (3.8) | 0 (0) | 1 (3.8) | 0 (0) | 1 (3.8) | 1 (3.8) | 0 (0) | 2 (7.7) | 0 (0) | 1 (3.8) | 2 (3.8) | |
| R | 1 (3.8) | 17 (65.4) | 0 (0) | 14 (53.8) | 4 (15.4) | 20 (76.9) | 0 (0) | 3 (11.5) | 8 (30.8) | 14 (53.8) | 3 (11.5) | |
|
| ||||||||||||
| | S | 1 (100) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 1 (100) | 0 (0) | 1 (100) |
| I | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| R | 0 (0) | 1 (100) | 0 (0) | 1 (100) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0 (0) | |
|
| ||||||||||||
| | S | 1 (50) | 0 (0) | 2 (100) | 1 (50) | 1 (50) | 0 (0) | 1 (100) | 1 (50) | 1 (50) | 1 (50) | 1 (50) |
| I | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| R | 1 (50) | 2 (100) | 0 (0) | 1 (50) | 1 (50) | 2 (100) | 0 (0) | 1 (50) | 1 (50) | 1 (50) | 1 (50) | |
|
| ||||||||||||
| Total | S | 41 (82) | 13 (26) | 48 (96) | 23 (48) | 38 (76) | 18 (36) | 28 (93) | 23 (77) | 20 (69) | 12 (41.4) | 24 (80) |
| I | 2 (4) | 4 (8) | 2 (4) | 1 (2) | 2 (4) | 2 (4) | 0 (0) | 3 (10) | 0 (0) | 1 (3.4) | 2 (7) | |
| R | 7 (14) | 33 (66) | 0 (0) | 25 (50) | 9 (20) | 30 (60) | 1 (7) | 4 (13) | 9 (31) | 16 (55) | 4 (13) | |
Note: AMP, ampicillin; CIP, ciprofloxacin; CRO, ceftriaxone; AMC, amoxicillin-clavulanate; CN, gentamicin; F, Nitrofurantoin; SXT, cotrimoxazole; NA, nalidixic acid; CAZ, ceftazidime; MEM, meropenem; VA, vancomycin; TE, tetracycline; ND, not done.
Multidrug resistance pattern of community and hospital-acquired bacterial isolates among Dessie Referral Hospital UTI suspected patients at Dessie, March-April, 2019.
| Isolates | Community-acquired isolates | Hospital-acquired isolates | ||
|---|---|---|---|---|
| Antimicrobial agents | N (%) | Antimicrobial agents | ||
| AMC, SXT, CXM | 1 (3.85) | AMP, AMOX-CLA, GEN | 1 (5.56) | |
| AMP, AMOX-CLAV, SXT, CTR | 1 (3.85) | AMP, AMOX-CLAV, TET, SXT, CXM | 1 (5.56 | |
| NAL, SXT, CTR | 1 (3.85) | AMOX-CLAV, SXT, CXM | 1 (5.56) | |
| AMP, AMOX-CLAV, TET | 2 (3.85) | AMP, AMOX-CLAV, TET CPRSXT, CXM | 1 (5.56) | |
| AMP, AMOX-CLAV, TET, SXT | 4 (3.85) | AMP AMOX-CLAV CPR GEN, NIT | 1 (5.56) | |
| TET, SXT, GEN | 1 (3.85) | AMP, TET, CPR | 1 (5.56) | |
| AMP, AMOX-CLAV NAL, TET, GEN | 1 (3.85) | AMP, NAL, TET | 1 (5.56) | |
| AMP, NAL, TET | 1 (3.85) | AMP, TET, CPR, SXT, CTR | 2 (5.56) | |
| AMP, AMOX-CLA, NAL TET, SXT | 2 (3.85) | AMP, AMOX-CLAV, CPR | 1 (5.56) | |
| AMP, AMOX-CLAV NAL, SXT | 1 (3.85) | AMP AMOX-CLAV, SXT | 1 (5.56) | |
| AMP, TET, SXT | 1 (3.85) | |||
| AMP, TET, SXT, GEN | 1 (3.85) | |||
| AMOX-CLAV, SXT | 1 (3.85) | |||
|
| ||||
| Total | 18 (69.2) | 11 (61.1) | ||
|
| ||||
| P | AMP, AMOX-CLAV, TET, SXT | 1 (100) | AMP, TET, SXT, GEN | 1 (33.3) |
| AMP, AMOX-CLAV, TET SXT | 1 (33.33) | |||
| AMP, AMOX-CLAV, TET, SXT, GEN, CTR | 1 (33.33) | |||
|
| ||||
| Total | 1 (100) | 3 (100) | ||
|
| ||||
| AMP, NAL, TET, SXT, GEN, CTR | 1 (50) | AMP, AMOX-CLAV, TET | 1 (20) | |
| AMP, AMOX-CLAV NAL, TET, CPR | 1 (50) | AMP, AMOX-CLV SXT, GEN, CTR | 1 (20) | |
| AMP, AMOX-CLAV, TET, CTR | 1 (20) | |||
| AMP, NAL, TET, CPR, SXT, CTR | 1 (20) | |||
| AMP, AMOX-CLAV, SXT | 1 (20) | |||
|
| ||||
| Total | 2 (100) | 5 (100) | ||
|
| ||||
| AMOX-CLAV, AMP, NAL, SXT, GEN, CTR | 1 (50) | |||
| AMP, AMOX-CLAV, TET, SXT, CTR | 1 (50) | |||
|
| ||||
| Total | 2 (100) | |||
|
| ||||
| TET, CPR, PEN, GEN | 1 (8.3) | TET, SXT, PEN | 3 (7.7) | |
| TET, CPR, SXT, PEN | 1 (8.3) | TET, CPR, SXT, GEN, NIT | 1 (7.7) | |
| TET, CPR, SXT, PEN | 1 (7.7) | |||
| CPR, SXT, PEN | 1 (7.7) | |||
| TET, PEN, NIT | 1 (7.7) | |||
| 7 (53.9) | ||||
|
| ||||
| Total | 2 (16.6) | |||
|
| ||||
| CONS [ | TET, CPR, SXT | 1 (12.5) | TET, PEN, GEN, CPR | 1 (16.6) |
| CONS [ | TET, PEN, GEN | 1 (12.5) | TET, SXT, PEN | 1 (16.6) |
| TET SXT, GEN | 1 (16.6) | |||
| TET, CPR, SXT, PEN, GEN | 1 (16.6) | |||
| Total | 2 (25) | 4 (66.7) | ||
Note: IPD = inpatient, OPD = outpatient department, CONs = coagulase-negative Staphylococcus, AMP = ampicillin, TET = tetracycline, PEN = penicillin, GEN = gentamycin, CPR = ciprofloxacillin, SXT = sulphamethoxazole-trimethoprim, NIT = nitrofurantoin, CTR = ceftriaxone, CXM = cefixime.